Hartline Investment Corp Boosts Stake in SPDR S&P Biotech Etf

Hartline Investment Corp Boosts Stake in SPDR S&P Biotech Etf

Hartline Investment Corp lifted its holdings in SPDR S&P Biotech ETF by 26.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,227 shares of the exchange traded fund's stock after buying an additional 7,901 shares during the period.

from Biotech News